McKesson Corporation (MCK)

Market Cap	106.89B
Revenue (ttm)	387.09B
Net Income (ttm)	4.03B
Shares Out	123.43M
EPS (ttm)	32.12
PE Ratio	26.96
Forward PE	21.05
Dividend	$3.28 (0.39%)
Ex-Dividend Date	Dec 1, 2025

Volume	754,555
Open	851.34
Previous Close	849.46
Day's Range	848.50 - 869.74
52-Week Range	558.13 - 869.74
Beta	0.39
Analysts	Strong Buy
Price Target	876.25 (+1.18%)
Earnings Date	Nov 5, 2025

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 51,000
• Stock Exchange: NYSE
• Ticker Symbol: MCK
• Website: https://www.mckesson.com

Financial Performance

In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Analyst Summary

According to 12 analysts, the average rating for MCK stock is "Strong Buy." The 12-month stock price target is $876.25, which is an increase of 1.18% from the latest price.

Price Target

$876.25

(1.18% upside)

Analyst Consensus: Strong Buy